http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2008128816-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D323-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D493-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D493-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-357
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-18
filingDate 2006-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2010-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2008128816-A
titleOfInvention ANTITUMEN COMPOUNDS
abstract 1. The compound of general formula I or a pharmaceutically acceptable salt, derivative, prodrug or stereoisomer thereof! ! where R1-16 are groups independently selected from hydrogen, protected or unprotected hydroxyl, substituted or unsubstituted C1-C24 alkyl, substituted or unsubstituted C2-C24 alkenyl, substituted or unsubstituted! C2-C24 alkynyl, = O, ORa, OCORa, NRaRb, NRaCORb, CONRaRb, CORa, COORa and halogen; ! X and Y are groups independently selected from substituted or unsubstituted C1-C24 alkyl, substituted or unsubstituted C2-C24 alkenyl, substituted or unsubstituted C2-C24 alkynyl, = O, ORa, OCORa, NRaRb, NRaCORb, CONRaRb, CORa, COORa and halogen; ! Ra and Rb are groups independently selected from hydrogen, halogen, substituted or unsubstituted C1-C12 alkyl, substituted or unsubstituted C2-C12 alkenyl, substituted or unsubstituted C2-C12 alkynyl, substituted or unsubstituted aryl, and substituted or unsubstituted heterocycle; and! the dashed line indicates the optional presence of a double bond. ! 2. The compound according to claim 1, where R1-16 are groups independently selected from hydrogen, protected or unprotected hydroxyl, ORa, OCORa, = O, NRaRb, NRaCORb, halogen, and substituted or unsubstituted C1-C24 alkyl. ! 3. The compound according to claim 3, where R1-7 and R9-15 are groups independently selected from hydrogen, hydroxyl, C1-C6 alkyl, and ORa. ! 4. The compound according to any one of claims 1 to 3, where R8 and R16 are = O. ! 5. The compound according to any one of claims 1 to 3, where X and Y are groups independently selected from substituted or unsubstituted C5-C12 alkyl and substituted or unsubstituted C5-C12 alkenyl. ! 6. The compound according to claim 5, where X and Y are groups independently selected from C5-C12 alkyl and C5-C12 alkenyl, which
priorityDate 2005-12-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310

Total number of triples: 17.